Jeffrey S. Bornstein, Director at Allovir, Inc. (ALVR), bought 5,000 shares at $4.64 ($23K) on 2022-04-26, disclosed to the SEC on 2022-04-28.
Open-market purchase of $23k ALVR by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| EOSE | BUY | 2022-11-14 | $26K | — | Filing → |
| ALVR | BUY | 2022-02-10 | $44K | — | Filing → |
| GE | BUY | 2017-02-02 | $148K | — | Filing → |